Progression Patterns and Post-Progression Survival in Recurred Intrahepatic Cholangiocarcinoma Patients: A Novel Prognostic Nomogram Based on Multicenter Cohorts

被引:2
|
作者
Zhao, Chongyu [1 ]
He, Chaobin [1 ]
Lu, Jiawei [2 ]
Huang, Xin [1 ]
Chen, Cheng [3 ]
Lin, Xiaojun [1 ]
机构
[1] Sun Yat sen Univ, Dept Pancreatobiliary Surg, State Key Lab Oncol South China, Collaborat Innovat Centerfor Canc Med Canc Ctr, Guangzhou, Peoples R China
[2] Dalian Med Univ, Dept Oncol, Hosp 2, Dalian, Peoples R China
[3] Dalian MedicalUnivers, Dept Cardiol, Affiliated Hosp 1, Dalian, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
基金
中国国家自然科学基金;
关键词
intrahepatic cholangiocarcinoma; post-progression survival; recurrence; prognosis; nomogram; HEPATOCELLULAR-CARCINOMA; MANAGEMENT; RESECTION; DIAGNOSIS; PREDICT;
D O I
10.3389/fonc.2022.832038
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundThe post-progression survival (PPS) of recurred intrahepatic cholangiocarcinoma (iCCA) patients relates to the characteristics of tumor progression. Moreover, the prediction model of PPS in those patients has not been well established. This study aimed at developing a novel nomogram for predicting PPS in recurred iCCA patients. MethodClinical characteristics were retrospectively collected in 396 patients diagnosed with iCCA from cohorts of Sun Yat-sen University Cancer Center (SYSUCC) and the First Hospital of Dalian Medical University (FHDMU). The PPS in patients with different progression patterns was investigated. The nomogram of PPS was established with the Cox regression model in the primary cohort. Then the nomogram was verified in the external validation cohort. ResultsLiver progression was the commonest pattern (42.08%) in recurred iCCA patients, while patients with local LN progression had significantly better PPS than those with other patterns. The independent prognostic factors comprised elevated CEA levels, tumor differentiation, N stage 8th, adjuvant therapy, Local LN metastasis, Liver Metastasis only, and Multiple Metastasis. The nomogram constructed on these factors achieved satisfied C-indexes of 0.794 (95% CI 0.769-0.828) and 0.827 (0.779-0.876) for the training and validation cohorts, respectively. These values were significantly higher than those of the 8th TNM stage system (all p < 0.001). The recurred iCCA patients could be precisely classified into high- and low-risk groups according to the cutoff point of this nomogram (p < 0.01). ConclusionThe investigation of progression patterns and the development of this nomogram can offer new evidence to precisely postoperative and post-progression management of iCCA patients.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Clinical Impact of the Relationship between Post-Progression Survival and Overall Survival in Extensive Disease Small Cell Lung Cancer Patients
    Imai, Hisao
    Mori, Keita
    Watase, Nodoka
    Fujimoto, Sakae
    Kaira, Kyoichi
    Yamada, Masanobu
    Minato, Koichi
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S726 - S727
  • [42] Recurrent Intrahepatic Cholangiocarcinoma: A Novel Prognostic Model to Predict Post-Recurrence Survival and Guide Treatment of Recurrence
    Tsilimigras, Diamantis
    Guglielmi, Alfredo
    Aldrighetti, Luca
    Weiss, Matthew
    Bauer, Todd
    Alexandrescu, Sorin
    Poultsides, George
    Maithel, Shishir K.
    Marques, Hugo
    Martel, Guillaume
    Pulitano, Carlo
    Shen, Feng
    Chaucy, Francois
    Koerkamp, Bas Groot
    Endo, Itaru
    Pawlik, Timothy M.
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S163 - S164
  • [43] Clinical impact of post-progression survival on overall survival in elderly patients with extensive disease small-cell lung cancer
    Imai, Hisao
    Mori, Keita
    Watase, Nodoka
    Kazama, Toshifumi
    Fujimoto, Sakae
    Kaira, Kyoichi
    Yamada, Masanobu
    Minato, Koichi
    THORACIC CANCER, 2016, 7 (06) : 655 - 662
  • [44] Post-Progression Survival in Patients with Non-Small Cell Lung Cancer with Clinically Acquired Resistance to Gefitinib
    Kim, Hyojeong
    Yun, Tak
    Lee, Young Joo
    Han, Ji-Youn
    Kim, Heung Tae
    Lee, Geon Kook
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2013, 28 (11) : 1595 - 1602
  • [45] Evaluation of Preoperative Inflammation-Based Prognostic Scores in Patients With Intrahepatic Cholangiocarcinoma: A Multicenter Cohort Study
    He, Chaobin
    Zhao, Chongyu
    Lu, Jiawei
    Huang, Xin
    Chen, Cheng
    Lin, Xiaojun
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [46] Post-progression survival is strongly linked to overall survival in refractory small-cell lung cancer patients who received amrubicin
    Imai, Hisao
    Kaira, Kyoichi
    Mori, Keita
    Watase, Nodoka
    Hisada, Takeshi
    Yamada, Masanobu
    Minato, Koichi
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2020, 16 (04) : 764 - 770
  • [47] Post-Progression Survival Is Strongly Linked to Overall Survival in Refractory Small-Cell Lung Cancer Patients Who Received Amrubicin
    Imai, H.
    Kaira, K.
    Mori, K.
    Watase, N.
    Hisada, T.
    Minato, K.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2184 - S2184
  • [48] Interim post-progression data and updated survival in patients with newly diagnosed advanced ovarian cancer in ATHENA-MONO
    Kristeleit, Rebecca
    O'Malley, David
    Lim, Myong Cheol
    Miller, Rowan
    Herzog, Thomas
    Wilson, Michelle
    De Vivo, Rocco
    Coleman, Robert
    Oaknin, Ana
    Oza, Amit
    Mikheeva, Olga
    Buscema, Joseph
    Chudecka-Glaz, Anita
    Van Le, Linda
    Van Gorp, Toon
    Moore, Kathleen
    Zagouri, Flora
    Morris, Robert
    Rob, Lukas
    Craib, Marcia
    Connor, Christy
    Shih, Danny
    Fujiwara, Keiichi
    Monk, Bradley
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S10 - S11
  • [49] Dose-Response Relationship between Post-Progression Bevacizumab Exposure and Survival among Metastatic Colorectal Cancer Patients
    Flick, E. Dawn
    Barr, Charles E.
    Fish, Susan M.
    Leon, Larry F.
    Mun, Yong
    Dalal, Darshan
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 244 - 245
  • [50] A novel prognostic nomogram for patients with surgically resected perihilar cholangiocarcinoma: a SEER-based study
    Li, Pengfei
    Song, Lujun
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (01)